L&K Biomed Participates in EUROSPINE 2025

Published 28 Oct.2025 13:46(KST)

Discussing Collaboration with Major Companies to Expand Supply Chain in Europe

L&K Biomed, a spinal implant manufacturer, announced on the 28th that it actively promoted its expandable cage product line at 'EUROSPINE 2025,' held in Copenhagen, Denmark, from October 22 to 24.

The Eurospine Society is recognized as one of the world's top three spine-related academic events, alongside the North American Spine Society (NASS) and the Global Spine Congress (GSC). More than 100 leading global spine companies and research institutes participate, covering a wide range of topics including the latest surgical techniques, advanced therapies, clinical research, and educational programs.

This year, L&K Biomed participated in the Eurospine Society meeting with its own independent booth for the first time. The company conducted demonstration sessions of its expandable cage product line for European medical professionals and collected feedback, thereby validating the competitiveness of its products. L&K Biomed also held strategic discussions with European medical professionals and local distributors to expand its market share for expandable cages within Europe. Additionally, based on insights gained from the conference, the company explored opportunities to expand into new markets not only in Europe but also in non-European countries adjacent to the region, such as those in the Middle East.

In July, L&K Biomed met with a global major company to expand the market for its expandable cage product line. For this conference, Kang Gukjin, Chairman of L&K Biomed, attended to discuss distribution strategies and co-marketing plans with the European management of the global major company, aiming to expand the supply chain within Europe. Through meetings with executives from major European countries such as the United Kingdom, Germany, Italy, the Netherlands, and Switzerland, the company sought ways to collaborate on product supply. The products received positive evaluations for their excellent quality and ease of use. Follow-up meetings are scheduled to continue in the future.

Kang Gukjin, Chairman of L&K Biomed, stated, "The quality agreement with the global major company is now in its final stage, with only the quality audit remaining," adding, "We are progressing smoothly according to the confirmed schedule."

A representative from L&K Biomed explained, "Europe is a globally significant market in terms of both technological advancement and market size in the spinal implant sector," and added, "We mobilized our core personnel at the conference to secure key partnerships within Europe."